secwatch.observer — SEC 8-K summary
======================================

Issuer:     ANAPTYSBIO, INC (ANAB)
CIK:        0001370053
Form:       8-K
Filed at:   2023-10-25T23:59:59+00:00
Accession:  0001370053-23-000058
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

AnaptysBio presents R&D slide deck on PD-1 agonist rosnilimab
-------------------------------------------------------------

- Presented rosnilimab (PD-1 agonist) R&D slide presentation on October 25, 2023.
- No specific clinical data, milestones, or financial guidance disclosed in the filing.
- Presentation provided as Exhibit 99.1; not filed, only furnished under Regulation FD.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1370053/000137005323000058/0001370053-23-000058-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1370053/000137005323000058/anab-20231025.htm
  HTML page:      https://secwatch.observer/filing/0001370053-23-000058

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer